ECA
OGN icon

Elevated Capital Advisors’s Organon & Co OGN Stock Holding History

Elevated Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240 Hold
40
– – ﹤0.01% 826
2025
Q4 		$287 Buy
+40
New +$316 ﹤0.01% 798

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Elevated Capital Advisors's OGN Position: Q1 2026 in Review

Elevated Capital Advisors held its Organon & Co (OGN) position steady in Q1 2026 at 40 shares worth $240. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Elevated Capital Advisors first reported a position in OGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $287 in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Elevated Capital Advisors held 40 shares of Organon & Co worth $240 as of Q1 2026.
  • Elevated Capital Advisors left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q1 2026, its #826 holding.
  • Elevated Capital Advisors first reported a position in Organon & Co in Q4 2025 and has held it in 2 quarters since.
  • Elevated Capital Advisors's Organon & Co position peaked at $287 in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Elevated Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.